Chinese Academy of Medical Sciences
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2004-07-08
- Employees
- -
- Market Cap
- -
Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer
- First Posted Date
- 2019-04-22
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 35
- Registration Number
- NCT03923166
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer
- First Posted Date
- 2019-04-22
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 32
- Registration Number
- NCT03923179
- Locations
- 🇨🇳
Cancer Hospital, ChineseAMS, Beijing, Beijing, China
Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 47
- Registration Number
- NCT03915132
- Locations
- 🇨🇳
Cancer hospital, Chinese Academy of Medical Sciences, Beijin, China
TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC
Not Applicable
- Conditions
- Non-Small Cell Lung Cancer Metastatic
- Interventions
- Radiation: Local radiation therapy
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 85
- Registration Number
- NCT03916913
- Locations
- 🇨🇳
Cancer Hospital/Institute, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma
Phase 2
Recruiting
- Conditions
- Stage II, IIINasopharyngeal Squamous Cell CarcinomaInduction ChemotherayConcurrent ChemoradiotherapyReduce Treatment Intensity
- Interventions
- First Posted Date
- 2019-04-09
- Last Posted Date
- 2021-01-29
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT03908372
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences, Beijin, China
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency
Phase 3
Recruiting
- Conditions
- Triple Negative Breast Cancer
- Interventions
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2019-03-21
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 200
- Registration Number
- NCT03876886
- Locations
- 🇨🇳
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Optical Assessment on Brain Death Via a Oxygen Supply Procedure
- Conditions
- Brain Death
- Interventions
- Procedure: Oxygen supply of high-low-high procedureProcedure: Oxygen supply of low-high-low procedureDevice: Optical monitor for hemodynamic parameter.
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT03864887
- Locations
- 🇨🇳
NIRS assessment for brain death, Tianjin, Tianjin, China
A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Interventions
- Drug: Oral NVB MetronomicDrug: Oral NVB Weekly
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 172
- Registration Number
- NCT03854617
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine
Phase 3
- Conditions
- Poliomyelitis
- Interventions
- Biological: bOPV(Liquid)Biological: bOPV(Candy)
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2019-01-29
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 1165
- Registration Number
- NCT03821441
- Locations
- 🇨🇳
Guangxi Provincial Center for Diseases Control and Prevention, Nanning, Guangxi, China
Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain
Not Applicable
- Conditions
- Muscle SpasticityOxygen Metabolism
- Interventions
- Procedure: Negative pressure therapy
- First Posted Date
- 2019-01-25
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Chinese Academy of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT03816787
© Copyright 2025. All Rights Reserved by MedPath